JAMA Clinical Reviews

JAMA Network

4.5 (435)
MEDICINE
UPDATED WEEKLY

Author interviews that explore the latest clinical reviews.

5 DAYS AGO

Diagnosis and Treatment of Atrial Fibrillation

The number of people living with atrial fibrillation (AF) is increasing, and they have a higher rate of cardiovascular events, chronic kidney disease, and dementia compared with people without AF. Emelia J. Benjamin, MD, ScM, an epidemiologist and cardiologist, discusses current diagnosis and treatment of AF with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Atrial Fibrillation

23 min
DEC 11

Allogeneic Stem Cell Donation

Allogeneic stem cell transplantation is a potentially life-saving therapy for some patients with hematologic and bone marrow cancers and certain nonmalignant conditions such as sickle cell disease. Hermioni L. Amonoo, MD, MPP, MPH, of Harvard Medical School and Dana-Farber Cancer Institute, joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the process of allogeneic stem cell donation. Related Content: Allogeneic Stem Cell Donation

14 min
DEC 11

JAMA Research at Critical Care Reviews 2024 (CCR Down Under)

JAMA Senior Editor Derek Angus, MD, MPH, and JAMA Associate Editor Christopher Seymour, MD, MSc, discuss 4 critical care trials published in JAMA and simultaneously presented at the 2024 CCR Down Under meeting in Melbourne, Australia, with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Electronic Sepsis Screening Among Patients Admitted to Hospital Wards Early Restrictive vs Liberal Oxygen for Trauma Patients High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure Do Sepsis Alerts Help? Reevaluating Respiratory Support in Acute Respiratory Failure—Insights From the RENOVATE Trial and Implications for Practice Is High-Flow Oxygen the Standard for All Patients With Acute Respiratory Failure? Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis

18 min
DEC 4

Loss of Obstetric Care in Rural and Urban Hospitals in the US

Access to obstetric care in US hospitals has been declining, while maternal mortality is on the rise. A new research letter published in JAMA quantifies losses and gains of obstetric care at rural and urban short-term acute care hospitals in the US between 2010-2022. Author Katy Kozhimannil, PhD, MPA, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: Obstetric Care Access at Rural and Urban Hospitals in the United States

14 min
NOV 26

Ovarian Aging

Ovarian aging is an important cause of infertility in women older than 35 years. Success rates of fertility treatment decline with age, most commonly due to declining ovarian function. Author Albert L. Hsu, MD, MS, of University of Cincinnati, Ohio, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content: Ovarian Aging and Fertility

14 min
NOV 19

Mpox Treatment Strategies, Clinical Presentation, and Diagnostic Approaches

Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Columbia University Irving Medical Center speaks with JAMA Deputy Editor Preeti Malani, MD, MSJ, about the transmission, diagnosis, management, and prevention of mpox. Related Content: Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies The Resurgence of Mpox in Africa Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination WHO Announces Mpox Global Plan, Appeals for Funding

17 min
NOV 11

Calcific Aortic Stenosis: Symptoms, Diagnosis, and Treatment

Calcific aortic stenosis affects approximately 12% of people >75 years in the US and worldwide leads to more than 100 000 deaths each year. Catherine M. Otto, MD, PhD, of the University of Washington School of Medicine, Seattle, discusses the symptoms, diagnosis, and treatment of aortic stenosis with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content: Calcific Aortic Stenosis

19 min
NOV 4

CAR T Cells and T-Cell Therapies for Cancer

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.” Related Content: CAR T Cells and T-Cell Therapies for Cancer Translational Science Reviews—A New JAMA Review

18 min

See All (404)

4.5

out of 5

435 Ratings

Bill Brandenburg, MD, Full Scope

03/07/2021

Full Scope

Most episodes great. Just listened to IBS. No mention of diet, exercise, or even fiber. Very little on stress. A bunch of marginal drugs mentioned. Try looking at the forest through the trees. Wake up to the effects of lifestyle on health.
Maternal mortality

08/10/2023

LEW0903

Political opinions inserted into a mortality conversation…. No thanks
Crap woke company

10/29/2021

hyper1984

AMA’s head so far up it’s own butt it can’t see how horrible an organization it’s become. Attacks it’s own people such as Ed Livingston and forces him to resign over some bull controversy. I’ll never support them again.
Non-Pharm Interventions

07/22/2021

PharmD123

As a pharmacist, I was hoping to develop more of a holistic picture of disease states beyond drug therapy with these podcasts. Very minimal focus on dietary/lifestyle modifications- not a great message to get across newer clinicians.